DNA, D(3'-AMINO-3'-DEOXY-P-THIO)(T-A-G-G-G-T-T-A-G-A-C-A-A), 5'-(O-(2-HYDROXY-3-((1-OXOHEXADECYL)AMINO)PROPYL) HYDROGEN PHOSPHOROTHIOATE)
Chronic Lymphoproliferative Diseases
Geron Corporationnucleic_acidPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Chronic Lymphoproliferative Diseases cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide M.D. Anderson Cancer Center | Phase 1 | CC |
il-15 enhanced engineered nk cells M.D. Anderson Cancer Center | Phase 1 | CC |
Fludarabine M.D. Anderson Cancer Center | Phase 1 | CC |
Tgfbr2 Ko Car27/Il-15 Nk Cells M.D. Anderson Cancer Center | Phase 1 | CC |
Same molecule, other indications
DNA, D(3'-AMINO-3'-DEOXY-P-THIO)(T-A-G-G-G-T-T-A-G-A-C-A-A), 5'-(O-(2-HYDROXY-3-((1-OXOHEXADECYL)AMINO)PROPYL) HYDROGEN PHOSPHOROTHIOATE) is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →